Spyre Therapeutics (SYRE) Change in Accrued Expenses (2015 - 2026)
Spyre Therapeutics' Change in Accrued Expenses was $4.71 million in Q3 2026, up 6.8% from $4.41 million a year earlier.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Change in Accrued Expenses (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Spyre Therapeutics' Change in Accrued Expenses was $8.06 million through Sep 30, 2026, down 26.6% year-over-year; for FY2025, it was -$764,000.
- In earlier years, Change in Accrued Expenses was $14.61 million in FY2024, -$4.89 million in FY2023, -$843,000 in FY2022 and -$373,000 in FY2021.
- The Q3 2026 figure marks the highest quarterly Change in Accrued Expenses since Q4 2024.
- Per Business Quant data, SYRE's Change in Accrued Expenses in the three quarters before Q3 2026 was -$3.43 million (Q2 2026), $3.65 million (Q1 2026) and $3.12 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Spyre Therapeutics | 9.40 Bn | 5.68 Bn | - | 4.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.71 Mn |
| Jun 30, 2026 | -3.43 Mn |
| Mar 31, 2026 | 3.65 Mn |
| Dec 31, 2025 | 3.12 Mn |
| Sep 30, 2025 | 4.41 Mn |
| Jun 30, 2025 | -2.30 Mn |
| Mar 31, 2025 | -6.00 Mn |
| Dec 31, 2024 | 14.87 Mn |
| Sep 30, 2024 | 7.37 Mn |
| Jun 30, 2024 | -15.77 Mn |
| Mar 31, 2024 | 8.15 Mn |
| Dec 31, 2023 | -891,000.00 |
| Sep 30, 2023 | -2.94 Mn |
| Jun 30, 2023 | 2.11 Mn |
| Mar 31, 2023 | -3.16 Mn |
| Dec 31, 2022 | 450,000.00 |
| Sep 30, 2022 | -416,000.00 |
| Jun 30, 2022 | 2.26 Mn |
| Mar 31, 2022 | -3.14 Mn |
| Dec 31, 2021 | 455,000.00 |
API Access
Spyre Therapeutics Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();